Popular Articles
Revitol Cellulite Cream

Novel Mechanism Controlling Tumor Growth In The Brain Revealed By Scripps Research Scientists
As survival rates among some patients with cancer continue to rise, so does the spread of these cancers to the brain - as much as 40 percent of all diagnosed brain cancers are considered metastatic, having spread from a primary cancer elsewhere in the body. Don't forget to buy zoloft online no prescription.

Vigils Held Worldwide To Protest Jailing Of Iranian Physicians Who Addressed HIV/AIDS
Health professionals on Tuesday held vigils in several cities worldwide to protest the imprisonment of Iranian brothers Kamiar and Arash Alaei -- physicians and leading HIV/AIDS advocates in the country -- following the release of Iranian-American journalist Roxana Saberi, the Albany Times Union reports. Vigils were held in cities such as New York City and Washington, D.C., as a day of global protest against the brothers" imprisonment. Vigils also were held in cities across Africa, Asia, Europe and South America, according to the Times Union.Jonathan Hutson -- a spokesperson for Physicians for Human Rights, which is leading a campaign for the brothers" release -- said, "The release of Ms. Saberi has shifted the world"s attention to the plight of others who are likewise jailed in Iran on trumped-up charges." He added, "This is not an issue of politics, but of global health. The only battle they were engaged in is the public health battle to prevent and treat the deadly epidemic of AIDS. They need to be allowed to return to their lifesaving work" (Grondahl, Albany Times Union, 5/13). Related Editorials

generic viagra online


News of the day
Glucose Metabolism And Recidivism Of Severe Violent Crimes In Alcohol Intoxications
It is commonly known that alcoholism and alcohol intoxications are connected with severe violent crimes such as homicides. For instance, in Finland even 80 per cent of these crimes happen in alcohol intoxications. It has not, however, been clear why only a minority of alcoholics in intoxications become irritated and impulsively aggressive or even commit severe violent crimes.
Health Insurance

CardioFocus Receives CE Mark For Atrial Fibrillation Ablation Catheter

CardioFocus, Inc. announced that it has received a CE Mark allowing the company to commence European marketing of the Endoscopic Ablation System (EAS) to treat patients with atrial fibrillation. The EAS is the latest generation, percutaneous catheter system that has been used clinically to treat patients with atrial fibrillation. This novel device incorporates both a micro-endoscope and light energy fibers to give physicians the capacity to actually see within the heart, and for the first time, visually direct the application of energy through a catheter. "We are grateful for the thorough review and the rapid response we received from our notified body," said Burke Barrett, CardioFocus VP of Clinical and Regulatory Affairs. Atrial Fibrillation is a common cardiac arrhythmia affecting several million people in Europe and over 2.5 million more in the United States. Symptoms can range from weakness and dizziness to more profound morbidity including stroke. Researchers believe that the considerable incidence and prevalence of the disease are increasing due to aging populations worldwide. Professional medical societies have endorsed the use of catheter ablation therapy when anti-arrhythmic drugs are ineffective, which can occur more than half the time. "The EAS represents a new era for catheter ablation of this complex arrhythmia. The CardioFocus device provides the electrophysiologist with a direct view of the cardiac anatomy that simply has not been available using other catheters. I believe that seeing the true orientation of the anatomy in full color and in real time, combined with the ability to safely and reliably deliver energy to the right target, increases the likelihood of delivering effective therapy," said Vivek Y. Reddy, MD, Director of Electrophysiology Laboratories at The Mount Sinai Medical Center in New York City. The EAS was the subject of several presentations at the recent Heart Rhythm Society meeting in Boston, highlighting excellent clinical results, simplified ease of use, reduced x-ray exposure and shortened procedure times. The CardioFocus device was also featured on the scientific program at the EuroPace meeting in Berlin in June, and will be prominent on the program at the Europe AF meeting in London in September. Since clinical results were reported at the 2009 Boston AF Symposium, physician interest in visually guided catheter ablation has been accelerating dramatically. As reported by several top centers, current catheter therapies are effective in barely 50% of patients receiving a single treatment. "CE Marking for our product highlights the great progress our company has made; our entire group has been dedicated to achieving this milestone. This facilitates more ambitious international research and European commercialization of our device. Cardiac electrophysiology is a focused area of medicine where a small company can make a big impact with the right product. Our interactions with well known specialists worldwide have provided enormous encouragement," commented Stephen W. Sagon, CardioFocus President and CEO. CardioFocus, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):